Leiomyosarkoma treatment cost in Israel typically involves specialized diagnostics like histopathology revision ranging from $500 to $800. Total expenses depend on the tumor stage and surgical complexity, with savings of 30–80% compared to the United States. Key treatment centers are primarily located in Tel Aviv, Jerusalem, and Haifa, offering multidisciplinary care for rare soft-tissue sarcomas.
Typical Leiomyosarkoma Treatment Costs in Israel
Bookimed Expert Insight: For complex soft-tissue sarcomas, patients benefit most from centers with dedicated sarcoma units. Sourasky Medical Center (Ichilov) features Israel's only specialized sarcoma center led by experts like Professor Ofer Merimsky. Facilities with JCI accreditation and Newsweek rankings, such as Hadassah and Rambam, offer high-value care for rare diseases. These centers utilize robotic surgery and AI-driven imaging to maintain a 90% oncology success rate.
| Israel | Turkey | Austria | |
| Proton-beam therapy | from $48,000 | from $70,000 | from $80,000 |
| High intensity focused ultrasound ablation (HIFU) | from $15,200 | from $4,000 | from $12,000 |
| CyberKnife | from $17,500 | from $4,750 | from $50,000 |
| Chemotherapy for breast cancer | from $22,500 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
Prof. Ofer Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – with specialized expertise in sarcoma treatment.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Dr. Levin leads the pediatric sarcoma program at Sourasky Medical Center and studied at Italy's world-leading Rizzoli Orthopaedic Institute.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.